Structure

Physi-Chem Properties

Molecular Weight:  500.31
Volume:  532.769
LogP:  3.044
LogD:  2.753
LogS:  -4.199
# Rotatable Bonds:  6
TPSA:  108.74
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.521
Synthetic Accessibility Score:  4.998
Fsp3:  0.8
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.334
MDCK Permeability:  1.613802851352375e-05
Pgp-inhibitor:  0.708
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.011
20% Bioavailability (F20%):  0.02
30% Bioavailability (F30%):  0.991

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.927
Plasma Protein Binding (PPB):  80.45668029785156%
Volume Distribution (VD):  0.496
Pgp-substrate:  11.54751968383789%

ADMET: Metabolism

CYP1A2-inhibitor:  0.003
CYP1A2-substrate:  0.374
CYP2C19-inhibitor:  0.019
CYP2C19-substrate:  0.913
CYP2C9-inhibitor:  0.055
CYP2C9-substrate:  0.84
CYP2D6-inhibitor:  0.001
CYP2D6-substrate:  0.127
CYP3A4-inhibitor:  0.096
CYP3A4-substrate:  0.487

ADMET: Excretion

Clearance (CL):  5.75
Half-life (T1/2):  0.886

ADMET: Toxicity

hERG Blockers:  0.022
Human Hepatotoxicity (H-HT):  0.174
Drug-inuced Liver Injury (DILI):  0.149
AMES Toxicity:  0.013
Rat Oral Acute Toxicity:  0.6
Maximum Recommended Daily Dose:  0.94
Skin Sensitization:  0.255
Carcinogencity:  0.554
Eye Corrosion:  0.004
Eye Irritation:  0.016
Respiratory Toxicity:  0.948

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC25750

Natural Product ID:  NPC25750
Common Name*:   Ganolucidic Acid A
IUPAC Name:   (6R)-6-[(5R,10S,13R,14R,15S,17R)-15-hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid
Synonyms:  
Standard InCHIKey:  XRXBNTYHQXKSAO-SXTFGQQDSA-N
Standard InCHI:  InChI=1S/C30H44O6/c1-16(12-18(31)13-17(2)26(35)36)20-14-24(34)30(7)19-8-9-22-27(3,4)23(33)10-11-28(22,5)25(19)21(32)15-29(20,30)6/h16-17,20,22,24,34H,8-15H2,1-7H3,(H,35,36)/t16-,17?,20-,22+,24+,28+,29-,30-/m1/s1
SMILES:  O=C(CC(C(=O)O)C)C[C@H]([C@H]1C[C@@H]([C@@]2([C@]1(C)CC(=O)C1=C2CC[C@@H]2[C@]1(C)CCC(=O)C2(C)C)C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1087131
PubChem CID:   20055993
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. DOI[10.1016/j.phytochem.2005.10.025]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[11520245]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[12045343]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[14695801]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[1791484]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. spore n.a. PMID[18827358]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies Nagano, Japan 2008-MAY PMID[20039640]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[20384295]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies n.a. n.a. PMID[20702092]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies n.a. n.a. PMID[21924611]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[22014750]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[22044278]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting body n.a. n.a. PMID[22047696]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[26222905]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[9635497]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO16609 Ganoderma sinense Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16609 Ganoderma sinense Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT520 Cell Line 3T3-L1 Mus musculus Inhibition = 22.0 % PMID[502294]
NPT204 Individual Protein Acetylcholinesterase Homo sapiens IC50 = 22970.0 nM PMID[502296]
NPT439 Individual Protein Butyrylcholinesterase Homo sapiens IC50 > 200000.0 nM PMID[502296]
NPT165 Cell Line HeLa Homo sapiens IC50 = 101000.0 nM PMID[502297]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 25340.0 nM PMID[502298]
NPT27 Others Unspecified Activity = 95.16 % PMID[502298]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC25750 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9773 High Similarity NPC241156
0.9663 High Similarity NPC125622
0.9663 High Similarity NPC95565
0.9451 High Similarity NPC10364
0.9348 High Similarity NPC205899
0.9149 High Similarity NPC204450
0.9149 High Similarity NPC195290
0.9149 High Similarity NPC56498
0.913 High Similarity NPC18319
0.9121 High Similarity NPC255809
0.9111 High Similarity NPC206810
0.9053 High Similarity NPC236390
0.9053 High Similarity NPC55872
0.9032 High Similarity NPC197386
0.9022 High Similarity NPC40765
0.9022 High Similarity NPC243525
0.9011 High Similarity NPC166906
0.9 High Similarity NPC107690
0.8989 High Similarity NPC54689
0.8958 High Similarity NPC28656
0.8936 High Similarity NPC88198
0.8936 High Similarity NPC157787
0.8925 High Similarity NPC106557
0.8913 High Similarity NPC37646
0.8913 High Similarity NPC318282
0.8913 High Similarity NPC317586
0.8913 High Similarity NPC470016
0.8913 High Similarity NPC173875
0.8913 High Similarity NPC469995
0.8913 High Similarity NPC174948
0.8901 High Similarity NPC470254
0.8817 High Similarity NPC328162
0.8817 High Similarity NPC3772
0.8817 High Similarity NPC328371
0.8817 High Similarity NPC305483
0.8817 High Similarity NPC96859
0.8804 High Similarity NPC184870
0.8778 High Similarity NPC477943
0.875 High Similarity NPC473038
0.8737 High Similarity NPC51370
0.8737 High Similarity NPC316964
0.8723 High Similarity NPC121339
0.8723 High Similarity NPC43747
0.871 High Similarity NPC469599
0.871 High Similarity NPC472932
0.871 High Similarity NPC48330
0.8696 High Similarity NPC243866
0.8696 High Similarity NPC152897
0.8696 High Similarity NPC66429
0.8681 High Similarity NPC289213
0.866 High Similarity NPC33973
0.866 High Similarity NPC70967
0.8652 High Similarity NPC212843
0.8646 High Similarity NPC124211
0.8636 High Similarity NPC209882
0.8632 High Similarity NPC166745
0.8632 High Similarity NPC235464
0.8617 High Similarity NPC173272
0.8617 High Similarity NPC42042
0.8587 High Similarity NPC150383
0.8587 High Similarity NPC23434
0.8587 High Similarity NPC154101
0.8571 High Similarity NPC470251
0.8571 High Similarity NPC216245
0.8571 High Similarity NPC2436
0.8571 High Similarity NPC135854
0.8557 High Similarity NPC53222
0.8556 High Similarity NPC312215
0.8542 High Similarity NPC287833
0.8523 High Similarity NPC168188
0.8523 High Similarity NPC470015
0.8511 High Similarity NPC263347
0.8485 Intermediate Similarity NPC51452
0.8469 Intermediate Similarity NPC251017
0.8462 Intermediate Similarity NPC242864
0.8462 Intermediate Similarity NPC131470
0.8462 Intermediate Similarity NPC143767
0.8462 Intermediate Similarity NPC183546
0.8462 Intermediate Similarity NPC294480
0.8454 Intermediate Similarity NPC163372
0.8454 Intermediate Similarity NPC302537
0.8438 Intermediate Similarity NPC471717
0.8438 Intermediate Similarity NPC16021
0.8427 Intermediate Similarity NPC473246
0.8421 Intermediate Similarity NPC155676
0.8387 Intermediate Similarity NPC297265
0.8384 Intermediate Similarity NPC235889
0.837 Intermediate Similarity NPC275740
0.837 Intermediate Similarity NPC214387
0.837 Intermediate Similarity NPC155479
0.837 Intermediate Similarity NPC86319
0.8367 Intermediate Similarity NPC308726
0.8367 Intermediate Similarity NPC119601
0.8352 Intermediate Similarity NPC99909
0.8351 Intermediate Similarity NPC144660
0.8351 Intermediate Similarity NPC218383
0.8351 Intermediate Similarity NPC474720
0.8351 Intermediate Similarity NPC299971
0.8333 Intermediate Similarity NPC122294
0.8333 Intermediate Similarity NPC474218
0.8333 Intermediate Similarity NPC94531
0.8333 Intermediate Similarity NPC320306
0.8333 Intermediate Similarity NPC216904
0.8333 Intermediate Similarity NPC123319
0.8333 Intermediate Similarity NPC311702
0.8333 Intermediate Similarity NPC469948
0.8317 Intermediate Similarity NPC295244
0.8316 Intermediate Similarity NPC184848
0.8316 Intermediate Similarity NPC45324
0.8316 Intermediate Similarity NPC69548
0.8316 Intermediate Similarity NPC222845
0.8316 Intermediate Similarity NPC162001
0.8316 Intermediate Similarity NPC200702
0.8315 Intermediate Similarity NPC469561
0.8315 Intermediate Similarity NPC271784
0.83 Intermediate Similarity NPC181265
0.8298 Intermediate Similarity NPC470376
0.8298 Intermediate Similarity NPC470375
0.8298 Intermediate Similarity NPC250575
0.8298 Intermediate Similarity NPC472930
0.8283 Intermediate Similarity NPC111323
0.828 Intermediate Similarity NPC46281
0.828 Intermediate Similarity NPC183283
0.828 Intermediate Similarity NPC477147
0.828 Intermediate Similarity NPC477149
0.828 Intermediate Similarity NPC20388
0.8265 Intermediate Similarity NPC99411
0.8265 Intermediate Similarity NPC472924
0.8265 Intermediate Similarity NPC474327
0.8261 Intermediate Similarity NPC48866
0.8261 Intermediate Similarity NPC471722
0.8261 Intermediate Similarity NPC247406
0.8247 Intermediate Similarity NPC275439
0.8247 Intermediate Similarity NPC114274
0.8247 Intermediate Similarity NPC112753
0.8247 Intermediate Similarity NPC147954
0.8242 Intermediate Similarity NPC472494
0.8242 Intermediate Similarity NPC31564
0.8242 Intermediate Similarity NPC474732
0.8242 Intermediate Similarity NPC222613
0.8242 Intermediate Similarity NPC474778
0.8242 Intermediate Similarity NPC474733
0.8242 Intermediate Similarity NPC28252
0.8242 Intermediate Similarity NPC55309
0.8242 Intermediate Similarity NPC118648
0.8242 Intermediate Similarity NPC145879
0.8242 Intermediate Similarity NPC475022
0.8242 Intermediate Similarity NPC472491
0.8242 Intermediate Similarity NPC155011
0.8242 Intermediate Similarity NPC72133
0.8235 Intermediate Similarity NPC258543
0.8235 Intermediate Similarity NPC304495
0.8235 Intermediate Similarity NPC241927
0.8229 Intermediate Similarity NPC472941
0.8229 Intermediate Similarity NPC456
0.8229 Intermediate Similarity NPC7124
0.8222 Intermediate Similarity NPC82902
0.8222 Intermediate Similarity NPC58841
0.8222 Intermediate Similarity NPC321187
0.8222 Intermediate Similarity NPC161423
0.8222 Intermediate Similarity NPC227064
0.8222 Intermediate Similarity NPC85774
0.8222 Intermediate Similarity NPC329043
0.8222 Intermediate Similarity NPC109512
0.8222 Intermediate Similarity NPC214043
0.8218 Intermediate Similarity NPC220974
0.8218 Intermediate Similarity NPC473037
0.8202 Intermediate Similarity NPC133391
0.8202 Intermediate Similarity NPC260956
0.8202 Intermediate Similarity NPC321289
0.8202 Intermediate Similarity NPC327969
0.82 Intermediate Similarity NPC119493
0.82 Intermediate Similarity NPC96268
0.82 Intermediate Similarity NPC477812
0.8191 Intermediate Similarity NPC86266
0.8191 Intermediate Similarity NPC212301
0.8191 Intermediate Similarity NPC110657
0.8191 Intermediate Similarity NPC63748
0.8191 Intermediate Similarity NPC19114
0.8182 Intermediate Similarity NPC234892
0.8182 Intermediate Similarity NPC87351
0.8182 Intermediate Similarity NPC281702
0.8182 Intermediate Similarity NPC473424
0.8173 Intermediate Similarity NPC221144
0.8172 Intermediate Similarity NPC123912
0.8172 Intermediate Similarity NPC186688
0.8172 Intermediate Similarity NPC477973
0.8172 Intermediate Similarity NPC1015
0.8172 Intermediate Similarity NPC215029
0.8172 Intermediate Similarity NPC476733
0.8172 Intermediate Similarity NPC31985
0.8172 Intermediate Similarity NPC473039
0.8163 Intermediate Similarity NPC307954
0.8163 Intermediate Similarity NPC327431
0.8163 Intermediate Similarity NPC476274
0.8155 Intermediate Similarity NPC197428
0.8152 Intermediate Similarity NPC96496
0.8152 Intermediate Similarity NPC58063
0.8152 Intermediate Similarity NPC475740
0.8152 Intermediate Similarity NPC317590

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC25750 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8298 Intermediate Similarity NPD6399 Phase 3
0.8235 Intermediate Similarity NPD6372 Approved
0.8235 Intermediate Similarity NPD6373 Approved
0.8222 Intermediate Similarity NPD3665 Phase 1
0.8222 Intermediate Similarity NPD3133 Approved
0.8222 Intermediate Similarity NPD3666 Approved
0.8191 Intermediate Similarity NPD5281 Approved
0.8191 Intermediate Similarity NPD5284 Approved
0.8172 Intermediate Similarity NPD5328 Approved
0.8144 Intermediate Similarity NPD6083 Phase 2
0.8144 Intermediate Similarity NPD6084 Phase 2
0.8125 Intermediate Similarity NPD5695 Phase 3
0.8119 Intermediate Similarity NPD5739 Approved
0.8119 Intermediate Similarity NPD6675 Approved
0.8119 Intermediate Similarity NPD6402 Approved
0.8119 Intermediate Similarity NPD7128 Approved
0.8077 Intermediate Similarity NPD6650 Approved
0.8077 Intermediate Similarity NPD6649 Approved
0.8043 Intermediate Similarity NPD7146 Approved
0.8043 Intermediate Similarity NPD5330 Approved
0.8043 Intermediate Similarity NPD7334 Approved
0.8043 Intermediate Similarity NPD6684 Approved
0.8043 Intermediate Similarity NPD7521 Approved
0.8043 Intermediate Similarity NPD6409 Approved
0.8041 Intermediate Similarity NPD4697 Phase 3
0.8022 Intermediate Similarity NPD4786 Approved
0.8 Intermediate Similarity NPD6079 Approved
0.7979 Intermediate Similarity NPD4753 Phase 2
0.7961 Intermediate Similarity NPD7320 Approved
0.7961 Intermediate Similarity NPD6899 Approved
0.7961 Intermediate Similarity NPD6881 Approved
0.7959 Intermediate Similarity NPD4755 Approved
0.7879 Intermediate Similarity NPD5696 Approved
0.7872 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7872 Intermediate Similarity NPD6903 Approved
0.7864 Intermediate Similarity NPD5701 Approved
0.7864 Intermediate Similarity NPD5697 Approved
0.7849 Intermediate Similarity NPD5279 Phase 3
0.7849 Intermediate Similarity NPD3618 Phase 1
0.781 Intermediate Similarity NPD7102 Approved
0.781 Intermediate Similarity NPD6883 Approved
0.781 Intermediate Similarity NPD7290 Approved
0.7802 Intermediate Similarity NPD3667 Approved
0.7802 Intermediate Similarity NPD4223 Phase 3
0.7802 Intermediate Similarity NPD4221 Approved
0.78 Intermediate Similarity NPD5286 Approved
0.78 Intermediate Similarity NPD4700 Approved
0.78 Intermediate Similarity NPD4696 Approved
0.78 Intermediate Similarity NPD5285 Approved
0.7788 Intermediate Similarity NPD6011 Approved
0.7755 Intermediate Similarity NPD5210 Approved
0.7755 Intermediate Similarity NPD4629 Approved
0.7742 Intermediate Similarity NPD5329 Approved
0.7736 Intermediate Similarity NPD6847 Approved
0.7736 Intermediate Similarity NPD8130 Phase 1
0.7736 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD6617 Approved
0.7736 Intermediate Similarity NPD6869 Approved
0.7732 Intermediate Similarity NPD4202 Approved
0.7723 Intermediate Similarity NPD5223 Approved
0.7714 Intermediate Similarity NPD6012 Approved
0.7714 Intermediate Similarity NPD6014 Approved
0.7714 Intermediate Similarity NPD6013 Approved
0.7692 Intermediate Similarity NPD4692 Approved
0.7692 Intermediate Similarity NPD4139 Approved
0.7684 Intermediate Similarity NPD6672 Approved
0.7684 Intermediate Similarity NPD5737 Approved
0.7677 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD5222 Approved
0.7677 Intermediate Similarity NPD5221 Approved
0.7664 Intermediate Similarity NPD8297 Approved
0.7664 Intermediate Similarity NPD6882 Approved
0.766 Intermediate Similarity NPD5690 Phase 2
0.766 Intermediate Similarity NPD4694 Approved
0.766 Intermediate Similarity NPD5280 Approved
0.7647 Intermediate Similarity NPD4633 Approved
0.7647 Intermediate Similarity NPD5226 Approved
0.7647 Intermediate Similarity NPD5224 Approved
0.7647 Intermediate Similarity NPD5225 Approved
0.7647 Intermediate Similarity NPD5211 Phase 2
0.7634 Intermediate Similarity NPD4197 Approved
0.7629 Intermediate Similarity NPD7515 Phase 2
0.7629 Intermediate Similarity NPD6050 Approved
0.7604 Intermediate Similarity NPD6080 Approved
0.7604 Intermediate Similarity NPD6904 Approved
0.7604 Intermediate Similarity NPD6673 Approved
0.76 Intermediate Similarity NPD5173 Approved
0.7596 Intermediate Similarity NPD6008 Approved
0.7576 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7573 Intermediate Similarity NPD5174 Approved
0.7573 Intermediate Similarity NPD5175 Approved
0.7573 Intermediate Similarity NPD4754 Approved
0.7556 Intermediate Similarity NPD3617 Approved
0.7527 Intermediate Similarity NPD4788 Approved
0.7526 Intermediate Similarity NPD5692 Phase 3
0.7526 Intermediate Similarity NPD5207 Approved
0.75 Intermediate Similarity NPD5141 Approved
0.7474 Intermediate Similarity NPD4688 Approved
0.7474 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7474 Intermediate Similarity NPD4693 Phase 3
0.7474 Intermediate Similarity NPD5205 Approved
0.7474 Intermediate Similarity NPD4690 Approved
0.7474 Intermediate Similarity NPD4138 Approved
0.7474 Intermediate Similarity NPD4689 Approved
0.7449 Intermediate Similarity NPD5694 Approved
0.7431 Intermediate Similarity NPD4632 Approved
0.7429 Intermediate Similarity NPD4768 Approved
0.7429 Intermediate Similarity NPD4767 Approved
0.7426 Intermediate Similarity NPD7902 Approved
0.7423 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD6335 Approved
0.732 Intermediate Similarity NPD5208 Approved
0.73 Intermediate Similarity NPD7748 Approved
0.7297 Intermediate Similarity NPD6274 Approved
0.7292 Intermediate Similarity NPD5786 Approved
0.7292 Intermediate Similarity NPD6098 Approved
0.729 Intermediate Similarity NPD4729 Approved
0.729 Intermediate Similarity NPD4730 Approved
0.729 Intermediate Similarity NPD5128 Approved
0.7273 Intermediate Similarity NPD5693 Phase 1
0.7273 Intermediate Similarity NPD8035 Phase 2
0.7273 Intermediate Similarity NPD6411 Approved
0.7273 Intermediate Similarity NPD8034 Phase 2
0.7263 Intermediate Similarity NPD3668 Phase 3
0.7257 Intermediate Similarity NPD7100 Approved
0.7257 Intermediate Similarity NPD7101 Approved
0.7232 Intermediate Similarity NPD6317 Approved
0.7232 Intermediate Similarity NPD6009 Approved
0.7228 Intermediate Similarity NPD5654 Approved
0.7204 Intermediate Similarity NPD4748 Discontinued
0.7204 Intermediate Similarity NPD5368 Approved
0.72 Intermediate Similarity NPD5133 Approved
0.7196 Intermediate Similarity NPD6412 Phase 2
0.7188 Intermediate Similarity NPD5363 Approved
0.7184 Intermediate Similarity NPD7638 Approved
0.7182 Intermediate Similarity NPD6053 Discontinued
0.7172 Intermediate Similarity NPD5785 Approved
0.7172 Intermediate Similarity NPD4096 Approved
0.7168 Intermediate Similarity NPD6313 Approved
0.7168 Intermediate Similarity NPD6314 Approved
0.7159 Intermediate Similarity NPD4245 Approved
0.7159 Intermediate Similarity NPD4244 Approved
0.7156 Intermediate Similarity NPD5135 Approved
0.7156 Intermediate Similarity NPD5249 Phase 3
0.7156 Intermediate Similarity NPD5169 Approved
0.7156 Intermediate Similarity NPD5251 Approved
0.7156 Intermediate Similarity NPD5250 Approved
0.7156 Intermediate Similarity NPD4634 Approved
0.7156 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7156 Intermediate Similarity NPD5248 Approved
0.7156 Intermediate Similarity NPD5247 Approved
0.7143 Intermediate Similarity NPD4518 Approved
0.7143 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6117 Approved
0.7143 Intermediate Similarity NPD6868 Approved
0.713 Intermediate Similarity NPD6908 Approved
0.713 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.713 Intermediate Similarity NPD6909 Approved
0.7129 Intermediate Similarity NPD6001 Approved
0.7129 Intermediate Similarity NPD7900 Approved
0.7129 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD5369 Approved
0.7115 Intermediate Similarity NPD7640 Approved
0.7115 Intermediate Similarity NPD7639 Approved
0.7111 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD4195 Approved
0.7091 Intermediate Similarity NPD5215 Approved
0.7091 Intermediate Similarity NPD5217 Approved
0.7091 Intermediate Similarity NPD5127 Approved
0.7091 Intermediate Similarity NPD5216 Approved
0.7087 Intermediate Similarity NPD5959 Approved
0.708 Intermediate Similarity NPD7115 Discovery
0.7071 Intermediate Similarity NPD6101 Approved
0.7071 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD6116 Phase 1
0.7053 Intermediate Similarity NPD6435 Approved
0.7053 Intermediate Similarity NPD4269 Approved
0.7053 Intermediate Similarity NPD4270 Approved
0.7045 Intermediate Similarity NPD3698 Phase 2
0.7043 Intermediate Similarity NPD6319 Approved
0.7033 Intermediate Similarity NPD6942 Approved
0.7033 Intermediate Similarity NPD3702 Approved
0.7033 Intermediate Similarity NPD7339 Approved
0.7021 Intermediate Similarity NPD4695 Discontinued
0.7009 Intermediate Similarity NPD7604 Phase 2
0.699 Remote Similarity NPD7614 Phase 1
0.6989 Remote Similarity NPD6115 Approved
0.6989 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6989 Remote Similarity NPD6114 Approved
0.6989 Remote Similarity NPD6118 Approved
0.6989 Remote Similarity NPD6697 Approved
0.6983 Remote Similarity NPD5983 Phase 2
0.6981 Remote Similarity NPD7632 Discontinued
0.6979 Remote Similarity NPD5362 Discontinued
0.6972 Remote Similarity NPD5168 Approved
0.6949 Remote Similarity NPD7492 Approved
0.6923 Remote Similarity NPD5733 Approved
0.6916 Remote Similarity NPD6052 Approved
0.6903 Remote Similarity NPD5167 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data